Also other findings, besides non-leukemic CD8+ and CD4+ T cells, further support the idea of an aberrant oligoclonal immune response against a patient-specific antigen as a disease-inducing and evolution-driving trigger in T-LGLL. Here, CD8A is linked to T-cell large granular lymphocyte leukemia.